Although data show that NMYC amplification initiates and drives the development of high-risk neuroblastomas, there is evidence that NMYC mRNA may also play an oncogenic role in neuroblastoma that is independent of NMYC protein [57,58,59,60]. Here, MYCN is linked to neuroblastoma.